Serine protease inhibitors and cytotoxic T lymphocytes

被引:0
|
作者
Ashton-Rickardt, Philip G. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Immunol, London W12 0NN, England
基金
英国惠康基金; 美国国家卫生研究院; 英国医学研究理事会;
关键词
serine protease inhibitors; cytotoxic T cells; apoptosis; GRANZYME-B INHIBITOR; CELLS IN-VIVO; RENAL-ALLOGRAFT REJECTION; PERFORIN-DEFICIENT MICE; MEDIATED CYTOTOXICITY; VIRAL-INFECTION; DENDRITIC CELLS; STEM-CELLS; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serine proteases control a wide variety of physiological and pathological processes in multi-cellular organisms, including blood clotting, cancer, cell death, osmoregulation, tissue remodeling, and immunity to infection. Cytotoxic T lymphocytes (CTLs) are required for adaptive cell-mediated immunity to intracellular pathogens by killing infected cells and through the development of memory T cells. Serine proteases not only allow a CTL to kill but also impose homeostatic control on CTL number. Serine protease inhibitors (serpins) are the physiological regulators of serine proteases' activity. In this review, I discuss the role of serpins in controlling the recognition of antigen, effector function, and homeostatic control of CTLs through the inhibition of physiological serine protease targets. An emerging view of serpins is that they are important promoters of cellular viability through their inhibition of executioner proteases. This view is discussed in the context of the T-lymphocyte survival during effector responses and the development and persistence of long-lived memory T cells. Given the important role serpins play in CTL immunity, I discuss the potential for developing new immunotherapeutic approaches based directly on serpins or knowledge gained from identifying their physiologically relevant protease targets.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 50 条
  • [1] Association of serine protease with the rise of intracellular calcium in cytotoxic T lymphocytes
    Koo, GC
    Luk, Y
    Talento, A
    Wu, J
    Sirotina, A
    Fischer, PA
    Blake, JT
    Nguyen, MP
    Parsons, W
    Poe, M
    CELLULAR IMMUNOLOGY, 1996, 174 (02) : 107 - 115
  • [2] A SERINE PROTEASE (CCP1) IS SEQUESTERED IN THE CYTOPLASMIC GRANULES OF CYTOTOXIC LYMPHOCYTES-T
    REDMOND, MJ
    LETELLIER, M
    PARKER, JMR
    LOBE, C
    HAVELE, C
    PAETKAU, V
    BLEACKLEY, RC
    JOURNAL OF IMMUNOLOGY, 1987, 139 (10): : 3184 - 3188
  • [3] TRANSCRIPTIONAL ACTIVATION OF THE HUMAN CYTOTOXIC SERINE PROTEASE GENE CSP-B IN LYMPHOCYTES-T
    HANSON, RD
    LEY, TJ
    MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) : 5655 - 5662
  • [4] INHIBITORY EFFECT OF REVERSIBLE SERINE PROTEASE INHIBITORS ON THE ACTIVITY OF CYTO-TOXIC LYMPHOCYTES-T
    ARAKAWA, K
    NAKAJIMA, H
    YOSHIDA, T
    YASUMURA, T
    AIKAWA, I
    OHMORI, Y
    OKA, T
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1152 - 1153
  • [5] RAPID LOSS OF PERFORIN AND SERINE PROTEASE RNA IN CYTOTOXIC LYMPHOCYTES EXPOSED TO SENSITIVE TARGETS
    BAJPAI, A
    KWON, BS
    BRAHMI, Z
    IMMUNOLOGY, 1991, 74 (02) : 258 - 264
  • [6] IMMUNOREACTIVITY OF SERINE PROTEASE INHIBITORS
    PARVEZ, Z
    MESSMORE, HL
    FAREED, J
    MONCADA, R
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 307 - 307
  • [7] DEFECTS IN SERINE PROTEASE INHIBITORS
    SAS, G
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 248 - 248
  • [8] Activity of granzyme A, a serine protease in the killing granules of cytotoxic T lymphocytes, is reduced in cells from HIV-infected hemophiliacs
    Chiang, CF
    Tenenbaum, SA
    Verret, CR
    Leissinger, CA
    Garry, RF
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (03) : 235 - 239
  • [9] Novel serine protease inhibitors
    Kore, Anilkumar R.
    Shanmugasundaram, Muthian
    PHARMACEUTICAL PATENT ANALYST, 2012, 1 (04) : 457 - 468
  • [10] Serine protease inhibitors and thrombosis
    Carrell, RW
    Zhou, A
    Jin, L
    Huntington, JA
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 157 - 157